COPD International   Your Support Network

You can learn to control this disease instead of letting it control you!

 

Return To The Main Library         <<<<>>>>         Return To The HomePage

 
 
SafetyAlerts
April 30, 2003

Able Laboratories Has Recalled Carisoprodol Tablets

The Food and Drug Administration (FDA) released the following information.

PRODUCT
Carisoprodol Tablets, USP, 350mg, 500 and 1000 tablet bottles. Recall # D-221-3.

CODE
1,000 tablet bottles -- 210049A exp. 9/04;
210050A exp. 9/04;
500 tablet bottles -- 210051A exp. 9/04;
210052A exp. 9/04; 210053A exp 10/04.

RECALLING FIRM/MANUFACTURER
Able Laboratories, Inc., South Plainfield, NJ, by letter dated January 15, 2003. Firm initiated recall is ongoing.

REASON
Incorrect tablet imprinting; some tablets bear the incorrect identification "A265" rather than "A266".

VOLUME OF PRODUCT IN COMMERCE
7,731 bottles.

DISTRIBUTION
Nationwide.

Send mail to: Webmaster@COPD-International.com with questions
or comments about this web site.
Copyright © 2002-2004 ----- COPD-International.com
Last modified:
May 2, 2003
Disclaimer